Related Experiment Video

Updated: May 31, 2026

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

Potent amyloidogenicity and pathogenicity of Aβ43

Takashi Saito1, Takahiro Suemoto, Nathalie Brouwers

  • 1Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan.

Nature Neuroscience
|July 5, 2011
PubMed

Insights

Alzheimer's disease research reveals amyloid-β 43 (Aβ43) is a potent neurotoxin. This overlooked peptide aggregates more readily than Aβ42, contributing significantly to Alzheimer's pathology and memory impairment.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Amyloid-β 42 (Aβ42) is a key player in Alzheimer's disease (AD) pathogenesis.
  • The role of the similarly abundant Aβ43 peptide in AD remains largely uncharacterized.
  • Presenilin mutations are linked to familial AD and altered amyloid-β production.

Purpose of the Study:

  • To investigate the role of Aβ43 in Alzheimer's disease pathogenesis.
  • To determine if Aβ43 is amyloidogenic and neurotoxic in vivo.
  • To explore the link between presenilin mutations and Aβ43 overproduction.

Main Methods:

  • Generation of knock-in mice with a presenilin-1 R278I mutation.
  • Crossbreeding mutant mice with amyloid precursor protein transgenic mice.
  • Biochemical analysis of amyloid plaques and assessment of cognitive function (short-term memory).

Main Results:

  • The presenilin-1 R278I mutation leads to Aβ43 overproduction and is embryonic lethal in homozygous state.
  • Elevated Aβ43 levels in heterozygous mice accelerated amyloid pathology and impaired short-term memory.
  • Aβ43 demonstrated a higher aggregation propensity and greater neurotoxicity compared to Aβ42.
  • Other pathogenic presenilin mutations also increased Aβ43 production, correlating with disease onset.

Conclusions:

  • Aβ43 is a potent, amyloidogenic, and neurotoxic peptide significantly involved in Alzheimer's disease.
  • Aβ43 accumulation in plaque cores mirrors that observed in human AD brains.
  • Targeting Aβ43 may offer a novel therapeutic strategy for Alzheimer's disease.

More Related Videos

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...